Nutriband Receives Hong Kong Patent Protection for Drug-Abuse Deterrence Patches

MT Newswires Live
2024/11/27

Nutriband (NTRB) said Wednesday it has received Hong Kong patent protection for its Aversa abuse-deterrence transdermal technology.

The company said it received a notice of publication of the registration and grant of a standard patent from the Hong Kong Intellectual Property Department for the technology.

The Aversa technology is now covered by patents issued in 46 countries and entities including the US, European Union, Japan, Korea, Russia, China, Canada, Mexico, and Australia.

The technology places aversive agents into transdermal patches to counteract the abuse of opioids and stimulants.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10